0000950170-23-063716 Sample Contracts

QUINCE THERAPEUTICS, INC. EXECUTIVE CHANGE IN CONTROL AND SEVERANCE AGREEMENT

Control and Severance Agreement • November 14th, 2023 • Quince Therapeutics, Inc. • Biological products, (no disgnostic substances) • California

• Contract Type
  Control and Severance Agreement
• Filed
  November 14th, 2023
• Company
  Quince Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  California

This Executive Change in Control and Severance Agreement (the "Agreement') is made and entered into by and between Charles Ryan ("Executive") and Quince Therapeutics, Inc. (the"Company"), effective as of September 1, 2023 (the"Effective Date").

DocuSlgn Envelope ID: F7C9E685-A526-42DF•A1CB-6FBDC9B4648B

Quince Therapeutics, Inc. • November 14th, 2023 • Biological products, (no disgnostic substances) • New Jersey

• Company
  Quince Therapeutics, Inc.
• Filed
  November 14th, 2023
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New Jersey

Quince Therapeutics, Inc. (the "Company") is pleased to offer you employment with the Company on the terms described below (the"Agreement''), beginning on September 1, 2023 or such date as otherwise agreed to by you and the Company (such actual date your employment begins (the "Start Date")).